Preparation for the treatment of brain atrophy
Patent Information
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- NV NUTRICIA
- Filing Date
- 2017-03-08
- Publication Date
- 2026-06-17
AI Technical Summary
There is a need to investigate whether dietetic and nutritional intervention can help prevent and/or reduce brain atrophy, particularly in subjects at risk of neurodegenerative diseases such as Alzheimer's disease, as existing studies have not adequately addressed the impact of nutritional intake on brain atrophy progression.
A combination of uridine, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), vitamin C, vitamin E, selenium, vitamin B6, vitamin B9, vitamin B12, and choline is administered to subjects to therapeutically prevent and slow down brain atrophy, with a focus on preserving brain volume and synaptic connectivity.
The composition significantly reduces hippocampus and brain atrophy, slows cognitive decline, and improves synaptic connectivity, demonstrating high compliance and low side effects in clinical studies.